TTField therapy with chemotherapy improved median overall and pain-free survival in pancreatic cancer, according to new data ...

A medically tailored meal (MTM) delivery program to reduce nutritional decline and improve treatment tolerance in patients with colorectal cancer (CRC): A pilot study.

Novocure (Nasdaq:NVCR) today announced positive results from the Phase 3 PANOVA-3 trial of its tumor-treating fields (TTFields) therapy.

The development of surgical techniques, chemotherapy, biological agents, and multidisciplinary approaches have made patients with unresectable colorectal liver metastases eligible for surgery. Many ...

Relapse patterns, risk factors, re-resectability and survival after curative treatment for metastatic colorectal cancer (mCRC): A RAXO substudy.

puncture-free survival or tumor resectability rate between the TTFields with gemcitabine and nab-paclitaxel and the gemcitabine and nab-paclitaxel arms. TTFields therapy was well-tolerated ...

The Bismuth–Corlette classification system provides an anatomic description of the tumor location and longitudinal extension in the biliary tree (Figure 3). It is limited due to its failure to ...

A new study explores the power of PET/MRI imaging to predict survival in patients with adenocarcinoma of the esophagogastric ...